(1R,2S,5S,6R,10S,15R,23R)-18-amino-1,2,8,8,15,22,22-heptamethyl-12-[5-(morpholin-4-ylmethyl)furan-3-yl]-19,20-diazahexacyclo[12.11.0.02,11.05,10.015,23.017,21]pentacosa-11,17(21),18-triene-6-carboxylic acid

C40H58N4O4 — CID 71065905

IUPAC(1R,2S,5S,6R,10S,15R,23R)-18-amino-1,2,8,8,15,22,22-heptamethyl-12-[5-(morpholin-4-ylmethyl)furan-3-yl]-19,20-diazahexacyclo[12.11.0.02,11.05,10.015,23.017,21]pentacosa-11,17(21),18-triene-6-carboxylic acid
SMILESCC1(C)C[C@@H]2C3=C(c4coc(CN5CCOCC5)c4)CC4[C@@]5(C)Cc6c(N)n[nH]c6C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@H]2[C@H](C(=O)O)C1
InChIInChI=1S/C40H58N4O4/c1-36(2)18-27-25(28(19-36)35(45)46)8-10-40(7)32(27)26(23-16-24(48-22-23)21-44-12-14-47-15-13-44)17-31-38(5)20-29-33(42-43-34(29)41)37(3,4)30(38)9-11-39(31,40)6/h16,22,25,27-28,30-31H,8-15,17-21H2,1-7H3,(H,45,46)(H3,41,42,43)/t25-,27-,28+,30-,31?,38-,39+,40+/m0/s1
InChIKeyJCGWFKNBAIRMIS-UWTXEGCFSA-N
MW658.93 g/mol
LogP7.70
Rot. Bonds4

About (1R,2S,5S,6R,10S,15R,23R)-18-amino-1,2,8,8,15,22,22-heptamethyl-12-[5-(morpholin-4-ylmethyl)furan-3-yl]-19,20-diazahexacyclo[12.11.0.02,11.05,10.015,23.017,21]pentacosa-11,17(21),18-triene-6-carboxylic acid

(1R,2S,5S,6R,10S,15R,23R)-18-amino-1,2,8,8,15,22,22-heptamethyl-12-[5-(morpholin-4-ylmethyl)furan-3-yl]-19,20-diazahexacyclo[12.11.0.02,11.05,10.015,23.017,21]pentacosa-11,17(21),18-triene-6-carboxylic acid (PubChem CID 71065905) has the molecular formula C40H58N4O4 and a molecular weight of 658.93 g/mol. Its IUPAC name is (1R,2S,5S,6R,10S,15R,23R)-18-amino-1,2,8,8,15,22,22-heptamethyl-12-[5-(morpholin-4-ylmethyl)furan-3-yl]-19,20-diazahexacyclo[12.11.0.02,11.05,10.015,23.017,21]pentacosa-11,17(21),18-triene-6-carboxylic acid.

Molecular Properties

Compound Name(1R,2S,5S,6R,10S,15R,23R)-18-amino-1,2,8,8,15,22,22-heptamethyl-12-[5-(morpholin-4-ylmethyl)furan-3-yl]-19,20-diazahexacyclo[12.11.0.02,11.05,10.015,23.017,21]pentacosa-11,17(21),18-triene-6-carboxylic acid
PubChem CID71065905
Molecular FormulaC40H58N4O4
Molecular Weight658.93 g/mol
Exact Mass658.45
IUPAC Name(1R,2S,5S,6R,10S,15R,23R)-18-amino-1,2,8,8,15,22,22-heptamethyl-12-[5-(morpholin-4-ylmethyl)furan-3-yl]-19,20-diazahexacyclo[12.11.0.02,11.05,10.015,23.017,21]pentacosa-11,17(21),18-triene-6-carboxylic acid
SMILESCC1(C)C[C@@H]2C3=C(c4coc(CN5CCOCC5)c4)CC4[C@@]5(C)Cc6c(N)n[nH]c6C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@H]2[C@H](C(=O)O)C1
InChIInChI=1S/C40H58N4O4/c1-36(2)18-27-25(28(19-36)35(45)46)8-10-40(7)32(27)26(23-16-24(48-22-23)21-44-12-14-47-15-13-44)17-31-38(5)20-29-33(42-43-34(29)41)37(3,4)30(38)9-11-39(31,40)6/h16,22,25,27-28,30-31H,8-15,17-21H2,1-7H3,(H,45,46)(H3,41,42,43)/t25-,27-,28+,30-,31?,38-,39+,40+/m0/s1
InChIKeyJCGWFKNBAIRMIS-UWTXEGCFSA-N
XLogP7.70
TPSA117.61 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds4
Heavy Atoms48
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500658.93
LogP ≤ 57.70
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Analyze (1R,2S,5S,6R,10S,15R,23R)-18-amino-1,2,8,8,15,22,22-heptamethyl-12-[5-(morpholin-4-ylmethyl)furan-3-yl]-19,20-diazahexacyclo[12.11.0.02,11.05,10.015,23.017,21]pentacosa-11,17(21),18-triene-6-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (1R,2S,5S,6R,10S,15R,23R)-18-amino-1,2,8,8,15,22,22-heptamethyl-12-[5-(morpholin-4-ylmethyl)furan-3-yl]-19,20-diazahexacyclo[12.11.0.02,11.05,10.015,23.017,21]pentacosa-11,17(21),18-triene-6-carboxylic acid?
The IUPAC name of (1R,2S,5S,6R,10S,15R,23R)-18-amino-1,2,8,8,15,22,22-heptamethyl-12-[5-(morpholin-4-ylmethyl)furan-3-yl]-19,20-diazahexacyclo[12.11.0.02,11.05,10.015,23.017,21]pentacosa-11,17(21),18-triene-6-carboxylic acid (CID 71065905) is (1R,2S,5S,6R,10S,15R,23R)-18-amino-1,2,8,8,15,22,22-heptamethyl-12-[5-(morpholin-4-ylmethyl)furan-3-yl]-19,20-diazahexacyclo[12.11.0.02,11.05,10.015,23.017,21]pentacosa-11,17(21),18-triene-6-carboxylic acid.
What is the SMILES notation for (1R,2S,5S,6R,10S,15R,23R)-18-amino-1,2,8,8,15,22,22-heptamethyl-12-[5-(morpholin-4-ylmethyl)furan-3-yl]-19,20-diazahexacyclo[12.11.0.02,11.05,10.015,23.017,21]pentacosa-11,17(21),18-triene-6-carboxylic acid?
The canonical SMILES for (1R,2S,5S,6R,10S,15R,23R)-18-amino-1,2,8,8,15,22,22-heptamethyl-12-[5-(morpholin-4-ylmethyl)furan-3-yl]-19,20-diazahexacyclo[12.11.0.02,11.05,10.015,23.017,21]pentacosa-11,17(21),18-triene-6-carboxylic acid is CC1(C)C[C@@H]2C3=C(c4coc(CN5CCOCC5)c4)CC4[C@@]5(C)Cc6c(N)n[nH]c6C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@H]2[C@H](C(=O)O)C1.
What is the InChIKey of (1R,2S,5S,6R,10S,15R,23R)-18-amino-1,2,8,8,15,22,22-heptamethyl-12-[5-(morpholin-4-ylmethyl)furan-3-yl]-19,20-diazahexacyclo[12.11.0.02,11.05,10.015,23.017,21]pentacosa-11,17(21),18-triene-6-carboxylic acid?
The InChIKey is JCGWFKNBAIRMIS-UWTXEGCFSA-N. The full InChI is InChI=1S/C40H58N4O4/c1-36(2)18-27-25(28(19-36)35(45)46)8-10-40(7)32(27)26(23-16-24(48-22-23)21-44-12-14-47-15-13-44)17-31-38(5)20-29-33(42-43-34(29)41)37(3,4)30(38)9-11-39(31,40)6/h16,22,25,27-28,30-31H,8-15,17-21H2,1-7H3,(H,45,46)(H3,41,42,43)/t25-,27-,28+,30-,31?,38-,39+,40+/m0/s1.
What are the key properties of (1R,2S,5S,6R,10S,15R,23R)-18-amino-1,2,8,8,15,22,22-heptamethyl-12-[5-(morpholin-4-ylmethyl)furan-3-yl]-19,20-diazahexacyclo[12.11.0.02,11.05,10.015,23.017,21]pentacosa-11,17(21),18-triene-6-carboxylic acid?
(1R,2S,5S,6R,10S,15R,23R)-18-amino-1,2,8,8,15,22,22-heptamethyl-12-[5-(morpholin-4-ylmethyl)furan-3-yl]-19,20-diazahexacyclo[12.11.0.02,11.05,10.015,23.017,21]pentacosa-11,17(21),18-triene-6-carboxylic acid has a molecular weight of 658.93 g/mol, XLogP of 7.70, 4 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,2S,5S,6R,10S,15R,23R)-18-amino-1,2,8,8,15,22,22-heptamethyl-12-[5-(morpholin-4-ylmethyl)furan-3-yl]-19,20-diazahexacyclo[12.11.0.02,11.05,10.015,23.017,21]pentacosa-11,17(21),18-triene-6-carboxylic acid is sourced from PubChem (CID 71065905), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).